Table 2.
Comparison of the voiding parameters of patients in Group 1 and Group 2 measured before and after treatment
| Group 1 (n = 34) |
Group 2 (n = 34) |
|||||
|---|---|---|---|---|---|---|
| Before treatment | 12th week | p | Before treatment | 12th week | p | |
| Daily urinations, n | 11.2±2.1 | 7.7±2.9 | <0.001 | 11.2±2.0 | 9.0±3.1 | 0.008 |
| Urine volume, mL | 252.2±81.7 | 261.7±77.5 | 0.622 | 261.4±94.4 | 258.0±82.0 | 0.815 |
| Qmax, mL/s | 11.0±2.7 | 14.8±2.6 | 0.001 | 11.1±2.6 | 12.8±2.9 | 0.005 |
| Qmean, mL/s | 6.0±1.1 | 8.0±1.0 | 0.001 | 6.0±1.1 | 6.7±1.1 | 0.007 |
| PVR, mL | 83.2±25.4 | 54.7±31.5 | <0.001 | 82.7±24.8 | 65.7±24.1 | 0.005 |
| Udi6, score | 13.5 | 9 | <0.001 | 13.5 | 12 | 0.002 |
| EMG, n (%) | 34 (100) | 14 (41.2) | 0.391a | 34 (100) | 22 (64.7) | 0.122a |
Data are presented as mean ± SD or as stated.
a
Intergroup comparison was performed using the χ2 test.